Robert Lisicki's Insider Trades & SAST Disclosures
Robert Lisicki's most recent trade in Zura Bio Ltd - Ordinary Shares - Class A was a trade of 1,153,000 Employee Share Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Lisicki.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zura Bio Ltd - Ordinary Sh... | Robert Lisicki | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 1,153,000 | 1,153,000 | - | - | Employee Share Option (Right to Buy) | |
| Cadrenal Therapeutics Inc | Robert Lisicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 20,000 | 20,000 | - | - | Stock Options | |
| Zura Bio Ltd - Ordinary Sh... | Robert Lisicki | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Employee Share Option (Right to Buy) | |
| Zura Bio Ltd - Ordinary Sh... | Robert Lisicki | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 1,050,000 | 1,050,000 | - | - | Employee Share Option (Right to Buy) | |
| Zura Bio Ltd - Ordinary Sh... | Robert Lisicki | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 1,000,000 | 1,000,000 | - | - | Stock options | |
| Cadrenal Therapeutics Inc | Robert Lisicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 50,000 | 50,000 | - | - | Stock Options | |
| Cadrenal Therapeutics Inc | Robert Lisicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2023 | 75,000 | 75,000 | - | - | Stock options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges